ERCP Clinical Trials

21 recruitingLast updated: May 21, 2026

There are 21 actively recruiting ercp clinical trials across 15 countries. Studies span Not Applicable, Phase 4, Phase 3, Phase 1. Top locations include Xi'an, Shaanxi, China, Hangzhou, Zhejiang, China, Shanghai, Shanghai Municipality, China. Updated daily from ClinicalTrials.gov.


ERCP Trials at a Glance

21 actively recruiting trials for ercp are listed on ClinicalTrialsFinder across 6 cities in 15 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Xi'an, Hangzhou, and Shanghai. Lead sponsors running ercp studies include Air Force Military Medical University, China, University of Calgary, and Branislav Kuncak.

Browse ercp trials by phase

About ERCP Clinical Trials

Looking for clinical trials for ERCP? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ERCP trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ERCP clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 21 trials

Recruiting
Phase 1

STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis

Pancreatic SurgeryChronic PainChronic Pancreatitis+7 more
Indiana University24 enrolled5 locationsNCT05603702
Recruiting
Not Applicable

Cold Water Irrigation Therapy as an Adjunct to Indomethacin for Post-Endoscopic Retrograde Cholangiopancreatography(ERCP) Pancreatitis

PancreatitisERCP Surgery
University of Kansas Medical Center950 enrolled1 locationNCT07330284
Recruiting

Factors for Prolonged Hospital Stays in Patients Undergoing ERCP

Post-ERCP Adverse EventsERCP Complications
Air Force Military Medical University, China504 enrolled2 locationsNCT07568626
Recruiting

IV Fluids and Post-ERCP Pancreatitis

ERCP
University of Calgary13,000 enrolled1 locationNCT05211206
Recruiting
Phase 4

Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis

Post-ERCP Acute Pancreatitis
University of Calgary505 enrolled1 locationNCT06260878
Recruiting
Not Applicable

Prevention of Desaturations Using Positive Airway Pressure or Capnometry During ERCP

HypoxemiaDesaturationERCP
Karl Landsteiner University of Health Sciences288 enrolled2 locationsNCT07056075
Recruiting
Phase 4

Effect of IV Lidocaine on Duodenal Peristalsis and Sedation in ERCP

SedationERCP
Ankara City Hospital Bilkent120 enrolled1 locationNCT07333859
Recruiting

Post-ERCP Pancreatitis - Prophylactic Measures Implementation Study (PEP-PROMIS)

Pancreatitis, AcuteERCPProphylaxis
Branislav Kuncak1,000 enrolled1 locationNCT07244432
Recruiting
Not Applicable

Effect of Deep Analgosedation vs. Endotracheal Intubation General Anesthesia on on Perioperative Sedation Related Adverse Events in Elderly ERCP Patients

Biliary and Pancreatic DiseasesEndoscopic Retrograde Cholangiopancreatography (ERCP)
Gang Chen170 enrolled1 locationNCT07017283
Recruiting
Phase 3

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

Post-ERCP Acute Pancreatitis
Johns Hopkins University4,874 enrolled5 locationsNCT05252754
Recruiting
Not Applicable

Indomethacin vs Diclofenac for Preventing PEP

PancreatitisERCPNon-steroidal Anti-inflammatory (NSAID)+2 more
Air Force Military Medical University, China4,050 enrolled20 locationsNCT07071441
Recruiting
Not Applicable

Rectal NSAIDs With/Without PD Stent for PEP Prevention

Post-ERCP Acute PancreatitisNon-steroid Anti-inflammatory DrugsPancreatic Duct Stent Placement
Air Force Military Medical University, China1,278 enrolled15 locationsNCT07117318
Recruiting
Not Applicable

Evaluation of the Benefit of Lidocaine on the Prevention of the Risk of Post Endoscopic Retrograde Cholangio-pancreatography Pancreatitis.

ERCP Surgery
GCS Ramsay Santé pour l'Enseignement et la Recherche1,800 enrolled1 locationNCT05667987
Recruiting
Phase 4

Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis

Post-ERCP pancreatitis
Changhai Hospital1,366 enrolled12 locationsNCT07088757
Recruiting
Not Applicable

Early vs Late Laparoscopic Cholecystectomy After Common Bile Duct Stones Clearance Through Ercp.

Laparoscopic CholecystectomyCholedocholithiasisBile Duct Injury+1 more
Khyber Teaching Hospital136 enrolled1 locationNCT07130864
Recruiting
Not Applicable

Prevention of Post-sphincterotomy Bleeding

Post-ERCP Bleeding
National Cheng-Kung University Hospital120 enrolled1 locationNCT06107504
Recruiting

An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreatitis

Post-ERCP Acute Pancreatitis
Radboud University Medical Center700 enrolled1 locationNCT05267379
Recruiting
Not Applicable

Early Pancreatic Stent Placement for Preventing PEP

Post-ERCP pancreatitisCholangiopancreatography, Endoscopic Rretrograde
The First Affiliated Hospital of Anhui Medical University768 enrolled2 locationsNCT06250803
Recruiting
Phase 3

Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis

Post-ERCP pancreatitis
Chinese University of Hong Kong1,734 enrolled7 locationsNCT03713879
Recruiting

Safety and efficacy of biodegradable biliary and pancreatic stents

Biliary anastomotic stricturePost-ERCP pancreatitisHepatico-jejunal stricture
Royal Prince Alfred Hospital60 enrolled1 locationACTRN12621001534875